← Open Payments lookup

EARL RUSSELL: Open Payments

NPI 1447412275 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$647 in 34 payments from 11 companies in 2025. Trend: 2023 $720 · 2024 $900 · 2025 $647

Food & beverage: $647
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$210
GlaxoSmithKline, LLC.7$123
Lilly USA, LLC4$73
Novo Nordisk Inc3$53
Bayer Healthcare Pharmaceuticals Inc.2$40
ABBVIE INC.2$40
Exact Sciences Corporation2$36
Averitas Pharma Inc.1$28
KYOWA KIRIN, INC.1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: FARXIGA, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, Kerendia, QULIPTA, Ozempic, QUTENZA.

Industry payments across MS — which companies pay providers there.